Survival outcomes of population-wide colonoscopy screening: reanalysis of the NordICC data
Tomer Meirson, Gal Markel, Daniel A Goldstein · 2024
Read Survival outcomes of population-wide colonoscopy screening: reanalysis of the NordICC data by Tomer Meirson, Gal Markel, Daniel A Goldstein (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11575051.txt.
Description
Tomer Meirson, Gal Markel, and Daniel Goldstein reanalyzed the NordICC trial of colonoscopy screening in a 2024 paper. Colonoscopy is widely used to prevent colorectal cancer, yet strong evidence for its benefit was lacking until NordICC, the first randomized trial of the practice. That trial found no clear benefit in the whole invited population, with hints of benefit only among those actually screened.
Reanalysis matters because how dropouts and crossovers are handled can tilt the verdict. The authors revisit survival outcomes with fresh statistical care. Screening policy for millions rides on this single trial's reading, so independent reanalysis is a public service. Their work sharpens what the trial can and cannot claim.
Catalog record
| CREATOR | Tomer Meirson, Gal Markel, Daniel A Goldstein |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 21 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |